Quarterly report pursuant to Section 13 or 15(d)

Licenses Acquired (Tables)

v2.4.1.9
Licenses Acquired (Tables)
3 Months Ended
Mar. 31, 2015
Research and Development [Abstract]  
Research and Development Arrangement, Contract to Perform for Others
Accordingly, the total purchase price of $7.4 million, broken out as follows, was reflected as Research and Development-licenses acquired in the Company’s Condensed Consolidated Statement of Operations for the three months ended March 31, 2015:
 
($ in thousands)
 
For the Three Months
Ended March 31,
2015
 
Fortress:
 
 
 
 
EGFR inhibitors
 
$
1,000
 
IV Tramadol
 
 
2,000
 
Fortress Companies:
 
 
 
 
Mustang
 
 
2,260
(1)
Checkpoint
 
 
1,000
 
Coronado SO
 
 
1,179
(2)
Total
 
$
7,439
 
 
(1)
Mustang: $2.0 million in cash and $260,000 of Mustang shares issued in connection with acquiring the license.
(2)
Coronado SO: $929,000 in cash and $250,000 of Coronado SO shares issued in connection with acquiring the license.